These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 39095854)

  • 1. Single-cell tumor heterogeneity landscape of hepatocellular carcinoma: unraveling the pro-metastatic subtype and its interaction loop with fibroblasts.
    Guo DZ; Zhang X; Zhang SQ; Zhang SY; Zhang XY; Yan JY; Dong SY; Zhu K; Yang XR; Fan J; Zhou J; Huang A
    Mol Cancer; 2024 Aug; 23(1):157. PubMed ID: 39095854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIF-1α promoted vasculogenic mimicry formation in hepatocellular carcinoma through LOXL2 up-regulation in hypoxic tumor microenvironment.
    Wang M; Zhao X; Zhu D; Liu T; Liang X; Liu F; Zhang Y; Dong X; Sun B
    J Exp Clin Cancer Res; 2017 Apr; 36(1):60. PubMed ID: 28449718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
    Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB
    Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclin-Dependent Kinase 4 is expected to be a therapeutic target for hepatocellular carcinoma metastasis using integrated bioinformatic analysis.
    Zhang JN; Wei F; Lei LH; Yang Y; Yang Y; Zhou WP
    Bioengineered; 2021 Dec; 12(2):11728-11739. PubMed ID: 34784846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unraveling the role of ADAMs in clinical heterogeneity and the immune microenvironment of hepatocellular carcinoma: insights from single-cell, spatial transcriptomics, and bulk RNA sequencing.
    Chen J; Yuan Q; Guan H; Cui Y; Fu C; Wei T; Liu K
    Front Immunol; 2024; 15():1461424. PubMed ID: 39346916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spatial transcriptomics reveals tumor-derived SPP1 induces fibroblast chemotaxis and activation in the hepatocellular carcinoma microenvironment.
    Tong W; Wang T; Bai Y; Yang X; Han P; Zhu L; Zhang Y; Shen Z
    J Transl Med; 2024 Sep; 22(1):840. PubMed ID: 39267037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of microRNA-141-3p in the progression and metastasis of hepatocellular carcinoma cell.
    Hou X; Yang L; Jiang X; Liu Z; Li X; Xie S; Li G; Liu J
    Int J Biol Macromol; 2019 May; 128():331-339. PubMed ID: 30695725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor-β-induced plasticity causes a migratory stemness phenotype in hepatocellular carcinoma.
    Malfettone A; Soukupova J; Bertran E; Crosas-Molist E; Lastra R; Fernando J; Koudelkova P; Rani B; Fabra Á; Serrano T; Ramos E; Mikulits W; Giannelli G; Fabregat I
    Cancer Lett; 2017 Apr; 392():39-50. PubMed ID: 28161507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hsa_circ_0003998 promotes epithelial to mesenchymal transition of hepatocellular carcinoma by sponging miR-143-3p and PCBP1.
    Song LN; Qiao GL; Yu J; Yang CM; Chen Y; Deng ZF; Song LH; Ma LJ; Yan HL
    J Exp Clin Cancer Res; 2020 Jun; 39(1):114. PubMed ID: 32552766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DEPTOR induces a partial epithelial-to-mesenchymal transition and metastasis via autocrine TGFβ1 signaling and is associated with poor prognosis in hepatocellular carcinoma.
    Chen J; Zhu H; Liu Q; Ning D; Zhang Z; Zhang L; Mo J; Du P; Liu X; Song S; Fan Y; Liang H; Liu J; Zhang B; Chen X
    J Exp Clin Cancer Res; 2019 Jun; 38(1):273. PubMed ID: 31228948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type IIA topoisomerase (TOP2A) triggers epithelial-mesenchymal transition and facilitates HCC progression by regulating Snail expression.
    Dong Y; Sun X; Zhang K; He X; Zhang Q; Song H; Xu M; Lu H; Ren R
    Bioengineered; 2021 Dec; 12(2):12967-12979. PubMed ID: 34939898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GINS1 promotes ZEB1-mediated epithelial-mesenchymal transition and tumor metastasis via β-catenin signaling in hepatocellular carcinoma.
    Liang J; Yao N; Deng B; Li J; Jiang Y; Liu T; Hu Y; Cao M; Hong J
    J Cell Physiol; 2024 May; 239(5):e31237. PubMed ID: 38468464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frizzled 2-induced epithelial-mesenchymal transition correlates with vasculogenic mimicry, stemness, and Hippo signaling in hepatocellular carcinoma.
    Ou H; Chen Z; Xiang L; Fang Y; Xu Y; Liu Q; Hu Z; Li X; Huang Y; Yang D
    Cancer Sci; 2019 Apr; 110(4):1169-1182. PubMed ID: 30677195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intergrated analysis of ELMO1, serves as a link between tumour mutation burden and epithelial-mesenchymal transition in hepatocellular carcinoma.
    Peng H; Zhang Y; Zhou Z; Guo Y; Huang X; Westover KD; Zhang Z; Chen B; Hua Y; Li S; Xu R; Lin N; Peng B; Shen S
    EBioMedicine; 2019 Aug; 46():105-118. PubMed ID: 31324602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-Cell and Spatial Transcriptome Profiling Identifies the Transcription Factor BHLHE40 as a Driver of EMT in Metastatic Colorectal Cancer.
    Yang S; Zhang D; Sun Q; Nie H; Zhang Y; Wang X; Huang Y; Sun Y
    Cancer Res; 2024 Jul; 84(13):2202-2217. PubMed ID: 38657117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FSTL1 Secreted by Activated Fibroblasts Promotes Hepatocellular Carcinoma Metastasis and Stemness.
    Loh JJ; Li TW; Zhou L; Wong TL; Liu X; Ma VWS; Lo CM; Man K; Lee TK; Ning W; Tong M; Ma S
    Cancer Res; 2021 Nov; 81(22):5692-5705. PubMed ID: 34551961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HEG1 indicates poor prognosis and promotes hepatocellular carcinoma invasion, metastasis, and EMT by activating Wnt/β-catenin signaling.
    Zhao YR; Wang JL; Xu C; Li YM; Sun B; Yang LY
    Clin Sci (Lond); 2019 Jul; 133(14):1645-1662. PubMed ID: 31278131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of IQGAP3 in metastasis and epithelial-mesenchymal transition in human hepatocellular carcinoma.
    Shi Y; Qin N; Zhou Q; Chen Y; Huang S; Chen B; Shen G; Jia H
    J Transl Med; 2017 Aug; 15(1):176. PubMed ID: 28810875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Over-expression of miR-106b promotes cell migration and metastasis in hepatocellular carcinoma by activating epithelial-mesenchymal transition process.
    Yau WL; Lam CS; Ng L; Chow AK; Chan ST; Chan JY; Wo JY; Ng KT; Man K; Poon RT; Pang RW
    PLoS One; 2013; 8(3):e57882. PubMed ID: 23483935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-cell profiling reveals the metastasis-associated immune signature of hepatocellular carcinoma.
    Zhong D; Shi Y; Ma W; Liang Y; Liu H; Qin Y; Zhang L; Yang Q; Huang X; Lu Y; Shang J
    Immun Inflamm Dis; 2024 May; 12(5):e1264. PubMed ID: 38780041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.